Smith Alan K. Insider Trades

Insider Trading History

Track insider trading activity for Smith Alan K.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $1.67k 22,307 shares
Last Trade
Apr 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108k 22,307 shares
$4.85
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $28.4k 380,000 shares
Last Trade
Feb 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.17M 380,000 shares
$13.60
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $520 6,956 shares
Last Trade
Jan 03, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.25k 589 shares
$14.00
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $117 1,562 shares
Last Trade
Jan 03, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.9k 1,563 shares
$14.00
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $564 7,545 shares
Last Trade
Jan 03, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.9k 1,563 shares
$14.00
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $514 6,865 shares
Last Trade
Jan 02, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$35.4k 2,344 shares
$15.10
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $447 5,982 shares
Last Trade
Jan 02, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.3k 883 shares
$15.10
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $351 4,687 shares
Last Trade
Jan 02, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$35.4k 2,344 shares
$15.10
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $5.61k 75,000 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 75,000 shares
$18.70
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $5.61k 75,000 shares
Last Trade
Feb 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.51M 75,000 shares
$33.50
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $338 4,521 shares
Last Trade
Jan 03, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.8k 589 shares
$32.00
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $382 5,110 shares
Last Trade
Jan 03, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$50k 1,562 shares
$32.00
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $526 7,031 shares
Last Trade
Jan 02, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.1k 2,344 shares
$33.30
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $331 4,431 shares
Last Trade
Jan 02, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.1k 2,344 shares
$33.30
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $2.95k 39,375 shares
Last Trade
Jul 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.04M 39,375 shares
$77.20
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $156 2,087 shares
Last Trade
Jan 09, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$43.1k 487 shares
$88.60
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $351 4,687 shares
Last Trade
Jan 03, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$153k 1,563 shares
$97.90
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $237 3,163 shares
Last Trade
Jan 03, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$153k 1,563 shares
$97.90
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $193 2,574 shares
Last Trade
Jan 03, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$57.7k 589 shares
$97.90
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Evp, Technical Operations
Holding Value $1.26k 16,875 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 26,250 shares
$92.30
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up